IBO: Impact BioMedical, Inc. Cash Calculated per Single Share

Corporate emblem and logo of Impact BioMedical Inc (IBO)

Should investors expect growth for Impact BioMedical Inc (IBO) given the technology licensing plans slated for 2026? The holding's potential in developing universal antivirals and biomedicine confirms its long-term prospects. Free cash flow per share demonstrates financial inertia, where the value 0.00 captures this metric. However, the risk of resource fragmentation in the face of niche players could slow scientific progress.

impactbiomedinc.com (IBO) - Cash per Share from 09/17/2024 to 11/20/2026

Analytical breakdowns for Impact BioMedical Inc

- stock value and consensus price forecast:
- cash position and cash flow details:
Comprehensive company analysis:IBO Impact BioMedical Inc
Manufactured product of Impact BioMedical Inc

Long-term investing requires strict liquidity control to minimize capital risks, which is critical for Impact BioMedical Inc (IBO) when creating isolated structures for patents within the biomedical ecosystem. By analyzing the cash cushion per share dynamics via GURU.Markets, an investor can see the ratio of total cash to the number of shares. An increase in this metric confirms the resource base for the commercialization of discoveries; however, excess funds without yield signal inefficient capital management.

Key competitors

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|Rani Therapeutics Holdings, Inc. - Cash Funds per Single Share|Cash Funds per Share Synergy CHC Corp. SNYR|Amount of Cash per Share RLYB|LEXX: Cash per Single Share|Amount of Cash per Share PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Cash Funds per Share|Cash per Single Share Aptorum|Cash per Single Share LYRA|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)